SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The Revenue for the quarter ended  December 2023 of Rs. 21230.00 millions grew by 10.92 % from Rs. 19140.00 millions.Net Profit recorded in the quarter ended December 2023 rise to 26.92% to Rs. 2970.00  millions  compared to R. 2340.00 millions in corresponding previous quarter.Operating Profit saw a handsome growth to 6900.00 millions from 6180.00 millions in the quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 21230.00 19140.00 10.92 63900.00 57750.00 10.65 76950.00 67420.00 14.14
Other Income -110.00 160.00 -168.75 150.00 560.00 -73.21 820.00 2040.00 -59.80
PBIDT 6900.00 6180.00 11.65 21890.00 19430.00 12.66 25470.00 23040.00 10.55
Interest 690.00 910.00 -24.18 2360.00 2040.00 15.69 2980.00 2360.00 26.27
PBDT 6210.00 5270.00 17.84 19530.00 17390.00 12.31 22490.00 20680.00 8.75
Depreciation 1910.00 1850.00 3.24 5660.00 4900.00 15.51 6720.00 6020.00 11.63
PBT 4300.00 3420.00 25.73 13870.00 12490.00 11.05 15770.00 14660.00 7.57
TAX 1330.00 1080.00 23.15 4400.00 4160.00 5.77 5250.00 4750.00 10.53
Deferred Tax 580.00 490.00 18.37 2000.00 2010.00 -0.50 2510.00 2220.00 13.06
PAT 2970.00 2340.00 26.92 9470.00 8330.00 13.69 10520.00 9910.00 6.16
Equity 1692.30 1692.30 0.00 1692.30 1692.30 0.00 1692.30 846.20 99.99
PBIDTM(%) 32.50 32.29 0.66 34.26 33.65 1.82 33.10 34.17 -3.14

Torrent Pharma Share Price

4157.30 64.15 (1.57%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×